Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.

Molecular testing for the BCR-ABL1 fusion gene by real time quantitative polymerase chain reaction (RT-qPCR) is the most sensitive routine approach for monitoring the response to therapy of patients with chronic myeloid leukaemia. In the context of tyrosine kinase inhibitor (TKI) therapy, the techni...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Foroni, L, Wilson, G, Gerrard, G, Mason, J, Grimwade, D, White, H, de Castro, D, Austin, S, Awan, A, Burt, E, Clench, T, Farruggia, J, Hancock, J, Irvine, A, Kizilors, A, Langabeer, S, Milner, B, Nickless, G, Schuh, A, Sproul, A, Wang, L, Wickham, C, Cross, N
التنسيق:	Journal article
اللغة:	English
منشور في:	2011

مواد مشابهة

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
حسب: Cross, N, وآخرون
منشور في: (2018)

Sequential quantitative minimal residual disease in BCR-ABL positive acute lymphoblastic leukaemia: Differential observations between major and minor fusion gene rearrangements and variation due to source material
حسب: Gerrard, G, وآخرون
منشور في: (2004)

No Benefit of BCR-ABL1 Screening in Polycythemia
حسب: STEPHEN E. LANGABEER
منشور في: (2016-07-01)

Targeting BCR-ABL1-positive leukaemias: a review article
حسب: Steven Leak, وآخرون
منشور في: (2023-01-01)

The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia
حسب: Renren Zheng, وآخرون
منشور في: (2024-06-01)

Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
حسب: Sarah L. McCarron, وآخرون
منشور في: (2013-01-01)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
حسب: Erin Clapper, وآخرون
منشور في: (2020-03-01)

Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche
حسب: Amy Dawson, وآخرون
منشور في: (2024-02-01)

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
حسب: Philippa C. May, وآخرون
منشور في: (2023-07-01)

No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
حسب: Victor Obeng Ofori, وآخرون
منشور في: (2020-10-01)

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
حسب: Berke, Z, وآخرون
منشور في: (2000)

BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients
حسب: Kizilors, A, وآخرون
منشور في: (2019)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.
حسب: Bench, A, وآخرون
منشور في: (2013)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
حسب: Shohei Kawakami, وآخرون
منشور في: (2022-01-01)

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
حسب: Baum Karina J, وآخرون
منشور في: (2008-06-01)

EVI1 expression in acute myeloid leukaemia.
حسب: Langabeer, SE, وآخرون
منشور في: (2001)

Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio
حسب: Ilaria Iacobucci, وآخرون
منشور في: (2007-03-01)

Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells
حسب: Chengwu Zeng, وآخرون
منشور في: (2024-10-01)

Co-expression of the CBFβ-MYH11 and BCR-ABL fusion genes in chronic myeloid leukaemia / Coexistenţa genelor de fuziune CBFβ-MYH11 şi BCR-ABL în leucemia mieloidă cronică
حسب: Popescu Roxana, وآخرون
منشور في: (2015-06-01)

Genomic amplification of <it>BCR/ABL1 </it>and a region downstream of <it>ABL1 </it>in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines
حسب: Virgili Anna, وآخرون
منشور في: (2010-09-01)

BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases
حسب: Anna Płotka, وآخرون
منشور في: (2023-07-01)

Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
حسب: Abdullah Aljedai, وآخرون
منشور في: (2015-01-01)

Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation
حسب: Stephen E. Langabeer, وآخرون
منشور في: (2023-01-01)

The other Achilles’ heel of BCR-ABL1
حسب: Kim De Keersmaecker
منشور في: (2012-01-01)

An In-house Method for Molecular Monitoring of BCR-ABL
حسب: Hakkı Ogun Sercan, وآخرون
منشور في: (2012-12-01)

Smart applications of bionanosensors for BCR/ABL fusion gene detection in leukemia
حسب: Karen Y.P.S. Avelino, وآخرون
منشور في: (2017-10-01)

p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia
حسب: Afsar A. Mian, وآخرون
منشور في: (2012-02-01)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
حسب: Dachuan Zeng, وآخرون
منشور في: (2022-05-01)

Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
حسب: Wulyo Rajabto, وآخرون
منشور في: (2018-03-01)

LMC y detección del gen de fusión BCR/ABL
حسب: C. G. Artigas Allaire
منشور في: (2006-04-01)

Prevalence of atypical BCR-ABL1 transcript types in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: implications for measurable residual disease
حسب: Úna Bhreathnach, وآخرون
منشور في: (2022-01-01)

Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL
حسب: Ahmed Makboul, وآخرون
منشور في: (2024-10-01)

OCT-1 function varies with cell lineage but is not influenced by BCR-ABL
حسب: Jane R. Engler, وآخرون
منشور في: (2011-02-01)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
حسب: Bench, A, وآخرون
منشور في: (2013)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
حسب: Saskia Maletzke, وآخرون
منشور في: (2022-01-01)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
حسب: Saskia Maletzke, وآخرون
منشور في: (2022-01-01)

Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
حسب: Jew Win Kuan, وآخرون
منشور في: (2024-06-01)

Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach
حسب: Caroline Busch, وآخرون
منشور في: (2023-11-01)

Changing the Subcellular Location of the Oncoprotein Bcr-Abl Using Rationally Designed Capture Motifs
حسب: Dixon, A, وآخرون
منشور في: (2011)

Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs.
حسب: Dixon, A, وآخرون
منشور في: (2012)